Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity

Geerts, 2004, Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 338S, 10.1378/chest.126.3_suppl.338S

Blaszyk, 2000, Factor V Leiden and morbid obesity in fatal postoperative pulmonary embolism, Arch Surg, 135, 1410, 10.1001/archsurg.135.12.1410

Brolin, 2001, Gastric bypass, Surg Clin North Am, 81, 1077, 10.1016/S0039-6109(05)70185-7

Sapala, 2003, Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis, Obes Surg, 13, 819, 10.1381/096089203322618588

Bern, 1983, Effects of low-dose warfarin on antithrombin III levels in morbidly obese patients, Surgery, 94, 78

De Pergola, 2002, Coagulation and fibrinolysis abnormalities in obesity, J Endocrinol Invest, 25, 899, 10.1007/BF03344054

Hirsch, 2004, Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 188S, 10.1378/chest.126.3_suppl.188S

Wu, 2000, Current practices in the prophylaxis of venous thromboembolism in bariatric surgery, Obes Surg, 10, 7, 10.1381/09608920060674021

Shepherd, 2003, Heparin thromboprophylaxis in gastric bypass surgery, Obes Surg, 13, 249, 10.1381/096089203764467153

Scholten, 2002, A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery, Obes Surg, 12, 19, 10.1381/096089202321144522

Hamad, 2005, Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study, Obes Surg, 15, 1368, 10.1381/096089205774859245

Gonzalez, 2006, Predictive factors of thromboembolic events in patients undergoing Roux-en-Y gastric bypass, Surg Obes Relat Dis, 2, 30, 10.1016/j.soard.2005.10.003

Abou-Nukta, 2006, Clinical pulmonary embolus after gastric bypass surgery, Surg Obes Relat Dis, 2, 24, 10.1016/j.soard.2005.09.016

Hubbard, 1991, Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Draft Statement, Obes Surg, 1, 257

Hamad, 2002, Recommended dosing of enoxaparin for thromboprophylaxis is subtherapeutic in the morbidly obese, Obes Surg, 12, 478

Kraus, 2002, Efficacy of body mass index (BMI) dependent dosing of enoxaparin in gastric bypass (GBP) patients, Obes Surg, 12, 203

Sanderink, 2002, The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers, Clin Pharmacol Ther, 72, 308, 10.1067/mcp.2002.127114

Podnos, 2003, Complications after laparoscopic gastric bypass: a review of 3464 cases, Arch Surg, 138, 957, 10.1001/archsurg.138.9.957

Higa, 2000, Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients—what have we learned?, Obes Surg, 10, 509, 10.1381/096089200321593706

DeMaria, 2002, Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity, Ann Surg, 235, 630, 10.1097/00000658-200205000-00005

Sugerman, 2001, Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease, Ann Surg, 234, 41, 10.1097/00000658-200107000-00007

Melinek, 2002, Autopsy findings following gastric bypass surgery for morbid obesity, Arch Pathol Lab Med, 126, 1091, 10.5858/2002-126-1091-AFFGBS

Miller, 2004, An approach to venous thromboembolism prophylaxis in laparoscopic Roux-en-Y gastric bypass surgery, Obes Surg, 14, 731, 10.1381/0960892041590944

Quebbeman, 2005, Continuous intravenous heparin infusion prevents peri-operative thromboembolic events in bariatric surgery patients, Obes Surg, 15, 1221, 10.1381/096089205774512528

Prystowsky, 2005, Prospective analysis of the incidence of deep vein thrombosis in bariatric surgery patients, Surgery, 138, 759, 10.1016/j.surg.2005.07.024

Carmody, 2006, Pulmonary embolism complicating bariatric surgery: detailed analysis of a single institution's 24-year experience, J Am Coll Surg, 203, 831, 10.1016/j.jamcollsurg.2006.08.020

Frederiksen, 2003, Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients, Br J Surg, 90, 547, 10.1002/bjs.4068

Bergqvist, 2002, Duration of prophylaxis against VTE with enoxaparin after surgery for cancer, N Engl J Med, 346, 975, 10.1056/NEJMoa012385

Spaw, 2005, Bleeding after laparoscopic gastric bypass: case report and literature review, Surg Obes Relat Dis, 1, 99, 10.1016/j.soard.2005.02.013

Nguyen, 2003, Early gastrointestinal hemorrhage after laparoscopic gastric bypass, Obes Surg, 13, 62, 10.1381/096089203321136601

Buchwald, 2004, Bariatric surgery: a systemic review and meta-analysis, JAMA, 292, 1724, 10.1001/jama.292.14.1724

Cendan, 2005, Utilization of intensive care resources in bariatric surgery, Obes Surg, 15, 1247, 10.1381/096089205774512681